CDNA News & Events

CareDx "announced the launch of VANTx(TM), an AI-powered, cloud-native clinical data and analytics platform designed to transform complex transplant data into insights that support clinical research and real-world evidence development. VANTx is designed for secure, scalable cohort analysis across longitudinal patient timelines that enables the evaluation of treatment trends, patient outcomes, and practice patterns. The platform is intended to support clinicians, transplant programs, and pharma partners in testing hypotheses to generate actionable findings for treatment protocol development, investigator-initiated studies, and clinical trial design."

CareDx announced that Keith Kennedy, the company's COO, will also assume the responsibilities of CFO and oversee the company's finance organization effective February 26. Kennedy has served as COO since September 2024. Nathan Smith announced on the company's quarterly earnings call that he will be stepping down from his role as CFO.

Sees FY26 adjusted EBITDA $30M-$45M.